Safety and Accuracy of Core Needle Biopsy for Soft Tissue Masses in an Ambulatory Setting
Sarcoma · 12.06.2018 · 2018 · 1-6
DOI: 10.1155/2018/1657864 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sarcoma, erschienen am 12.06.2018. Verfasst von J Brock Walker und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Arizona College of Medicine, Phoenix, AZ, USA. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Percutaneous needle biopsy has been found to be a safe and accurate method for the initial investigation of soft tissue masses. The notion exists that needle biopsies should be performed in specialized sarcoma centers, which can place a financial burden on patients without a sarcoma center near their place of residence. There is no consensus in the current literature regarding the diagnostic accuracy and clinical utility of clinic-based percutaneous core needle biopsy performed by community orthopedic surgeons with fellowship training in musculoskeletal oncology. Questions/Purposes . Our primary goal was to determine if office-based core needle biopsy of soft tissue masses could safely yield accurate diagnoses when performed by a community orthopedic surgeon with fellowship training in musculoskeletal oncology. Patients and Methods . We retrospectively reviewed the charts of 105 patients who underwent percutaneous core needle biopsy of soft tissue masses in a community clinic. All procedures were performed by one fellowship-trained musculoskeletal oncologist. Accuracy of the initial clinic-based needle biopsy was determined through comparison to the results of pathological analysis of the surgically excised masses. Final data analysis included 69 patients who underwent both clinic-based biopsy and subsequent surgical excision of their masses.
Results
We found clinic-based biopsies to be 87.0% accurate for exact diagnosis and 94.2% accurate in determining whether the mass was benign or malignant ( p < 0.0001 ). Minor complications related to the clinic-based biopsy occurred in 5.80% of cases, with no documentation of major complications.
Conclusions
Our results provide evidence that office-based percutaneous biopsy can be administered safely and yield accurate, clinically useful results when performed by a fellowship-trained musculoskeletal oncologist.
Autor:innen und Institutionen
- University of Arizona College of Medicine, Phoenix, AZ, USA.
- The CORE Institute, Phoenix, AZ, USA.
ORCID-Profile: J Brock Walker, Amalia Decomas
Zitieren
APA
Walker, J. B., Stockwell, E., Worhacz, K., Kang, P., & Decomas, A. (2018). Safety and Accuracy of Core Needle Biopsy for Soft Tissue Masses in an Ambulatory Setting. Sarcoma, 2018, 1-6. https://doi.org/10.1155/2018/1657864
Vancouver
Walker JB, Stockwell E, Worhacz K, Kang P, Decomas A. Safety and Accuracy of Core Needle Biopsy for Soft Tissue Masses in an Ambulatory Setting. Sarcoma. 2018;2018:1-6. doi:10.1155/2018/1657864
BibTeX
@article{Walker2018,
author = {Walker, J Brock and Stockwell, Erin and Worhacz, Kellen and Kang, Paul and Decomas, Amalia},
title = {Safety and Accuracy of Core Needle Biopsy for Soft Tissue Masses in an Ambulatory Setting},
journal = {Sarcoma},
year = {2018},
volume = {2018},
pages = {1--6},
doi = {10.1155/2018/1657864}
}
EUVIMED